The pathogenesis and effects of glucagon-like peptide-1 receptor agonist on diabetic cardiomyopathy.
10.3760/cma.j.cn112148-20230112-00025
- Author:
Le Qun ZHOU
1
;
Yi Da TANG
1
Author Information
1. Department of Cardiology and Institute of Vascular Medicine, Peking University Third Hospital, National Health Commission Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptides, Key Laboratory of Molecular Cardiovascular Science, Ministry of Education, Beijing Key Laboratory of Cardiovascular Receptors Research, Beijing 100191, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Glucagon-Like Peptide-1 Receptor/agonists*;
Diabetic Cardiomyopathies/drug therapy*;
Diabetes Mellitus, Type 2
- From:
Chinese Journal of Cardiology
2023;51(4):440-442
- CountryChina
- Language:Chinese
